These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6891110)

  • 1. A sensitive assay for tissue plasminogen activator.
    Rånby M; Norrman B; Wallén P
    Thromb Res; 1982 Sep; 27(6):743-9. PubMed ID: 6891110
    [No Abstract]   [Full Text] [Related]  

  • 2. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
    Karlan BY; Clark AS; Littlefield BA
    Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive and specific assay for plasminogen activators.
    Smith DS; Harmon J; Owen WG
    Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
    Rijken DC; Wijngaards G; Welbergen J
    J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies.
    Nielsen LS; Grøndahl-Hansen J; Andreasen PA; Skriver L; Zeuthen J; Danø K
    J Immunoassay; 1986; 7(3):209-28. PubMed ID: 3091639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
    Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
    J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on tissue culture plasminogen activator. II. The detection and assay of urokinase and plasminogen activator from LLC-PK cultures (porcine) by the synthetic substrate Nalpha-benzyloxycarbonyl-glycyl-glycyl-arginyl-4-methoxy-2-napthylamide.
    Huseby RM; Clavin SA; Smith RE; Hull RN; Smithwick EL
    Thromb Res; 1977 May; 10(5):679-87. PubMed ID: 882957
    [No Abstract]   [Full Text] [Related]  

  • 8. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
    Stephens R; Leung KC; Pöllänen J; Salonen EM; Vaheri A
    J Immunol Methods; 1987 Dec; 105(2):245-51. PubMed ID: 3121752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the plasminogen activator activity of the human glomerulus.
    Bergstein JM; Riley M; Bang NU
    Kidney Int; 1988 Apr; 33(4):868-74. PubMed ID: 3386139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activators in alveolar bone in man.
    Björlin G; Ljungnér H; Astedt B
    Acta Odontol Scand; 1986 Jun; 44(3):173-5. PubMed ID: 3461663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methods of derivation and physico-chemical properties of plasminogen activators].
    Makogonenko EM
    Ukr Biokhim Zh (1978); 1983; 55(3):344-54. PubMed ID: 6191419
    [No Abstract]   [Full Text] [Related]  

  • 12. Human synovial fibroblasts produce urokinase-type plasminogen activator.
    Medcalf RL; Hamilton JA
    Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymatic determination of plasminogen activators].
    Fischer BE
    Z Med Lab Diagn; 1988; 29(6):327-32. PubMed ID: 2973186
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoradiometric quantification of tissue plasminogen activator secreted by fetal organs. Comparison with urokinase.
    Holmberg L; Kristoffersson AC; Lecander I; Wallén P; Astedt B
    Scand J Clin Lab Invest; 1982 Jun; 42(4):347-54. PubMed ID: 6753100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.
    Duffy MJ; O'Grady P; Devaney D; O'Siorain L; Fennelly JJ; Lijnen HJ
    Cancer; 1988 Aug; 62(3):531-3. PubMed ID: 3134120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
    Wijngaards G
    Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.
    Camiolo SM; Markus G; Evers JL; Hobika GH; DePasquale JL; Beckley S; Grimaldi JP
    Int J Cancer; 1981 Feb; 27(2):191-8. PubMed ID: 6169657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and localization of urokinase-type plasminogen activator in human NK-cells.
    Carpén O; Saksela O; Saksela E
    Int J Cancer; 1986 Sep; 38(3):355-60. PubMed ID: 3091511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.